Flucinar gel 15 g — Made in Poland— Free Delivery
(Flucinar )
Availability: In Stock
Free Shipping!
If your country is on the checkout list, we deliver to you.
US and the Rest of the World: 9 to 20 business days
Delivery Timeframes:
Europe: 7 to 18 business daysUS and the Rest of the World: 9 to 20 business days
Description Flucinar gel 15 g — Made in Poland— Free Delivery
Indications
Short-term treatment of acute and severe non-infectious inflammatory skin diseases (without exudation) that are accompanied by persistent itching or hyperkeratosis: seborrheic dermatitis, atopic dermatitis, nodular urticaria (papular urticaria), allergic contact dermatitis, erythema multiforme, lupus erythematosus, psoriasis, lichen planus.
Application
Designed for topical use. the preparation should be applied in a thin layer on the affected skin 1-2 times a day.
Do not use the preparation under an occlusive dressing. Only with psoriasis is it allowed to use a closed bandage, which should be changed daily.
Treatment should not be carried out continuously for more than 2 weeks. Do not use the preparation on the skin of the face for more than 1 week. During the week, it is recommended to use no more than 15 g of ointment / gel (1 tube).
With caution, under the supervision of a doctor, use the preparation in children over the age of 2 years - only 1 time per day on a small area of \u200b\u200bthe skin; do not apply to the face.
Contraindications
Skin manifestations of syphilis, skin tuberculosis, pyoderma, chickenpox, herpes, actinomycosis, blastomycosis, sporotrichosis, diaper dermatitis, anogenital itching, nevus; atheroma, hemangioma, xanthoma, skin neoplasms, wounds and ulcerative lesions of the skin, wounds at the application sites, numerous psoriatic plaques, trophic ulcers associated with varicose veins, erosive and ulcerative lesions of the digestive tract.
It should not be used for bacterial, viral and fungal infections of the skin, acne vulgaris and rosacea, perioral dermatitis (dermatitis perioralis), after preventive vaccinations, as well as in case of confirmed hypersensitivity to fluocinolone acetonide or other GCS and other components of the preparation.
Should not be used in children under 2 years of age.
It is not recommended to use the preparation in the first trimester of pregnancy, during breastfeeding.
Side effects
From the skin and subcutaneous tissue: acne-like lesions, post-steroid purpura, epidermal growth inhibition, burning, itching, irritation, rash, subcutaneous tissue atrophy, dry skin, excessive body hair growth or alopecia, depigmentation or hyperpigmentation of the skin, atrophy and violations of skin integrity , telangiectasia, furunculosis, atrophic streaks, secondary infections, local skin reactions (including perioral, contact, allergic dermatitis). in some cases, urticaria or maculopapular rash may appear, or exacerbation of existing pathological lesions.
From the side of the organ of vision. When applied externally to the skin of the eyelids, cataracts or glaucoma can sometimes develop.
Systemic violations. The use of the preparation under an occlusive dressing, given the increased absorption, can cause a pronounced systemic effect, which manifests itself in the form of edema, hypertension, and a decrease in the body's resistance to infections.
Systemic unwanted effects. Secondary immunodeficiency (exacerbation of chronic infectious diseases, generalization of the infectious process, development of opportunistic infections), gastritis, steroid gastric ulcer, hyperglycemia, glucosuria, slowdown in reparative processes, adrenal insufficiency, inhibition of growth and development in children, Itsenko-Cushing's syndrome.
From the immune system: allergic reactions or hypersensitivity reactions are possible.
special instructions
The gel is especially suitable for the treatment of hairy skin and in patients who do not tolerate the basis of ointments and creams. the gel form allows it to be applied in small amounts, and thus to apply low doses of the preparation to large areas of the skin, as well as to apply to the skin of parts of the body covered with hair.
Treatment must be carried out under the supervision of a physician.
Before each re-application of the preparation, the remnants of the old preparation should be washed off with a soap solution or an antiseptic solution. It is recommended to wear loose clothing during treatment. Do not apply on the skin of the mammary glands.
Do not use the preparation simultaneously with other preparations for external use.
Periodic monitoring of adrenal function is shown by determining cortisol in the blood and urine after stimulation of the adrenal glands with ACTH with prolonged use.
Under special supervision, the ointment / gel should be used in patients with psoriasis, since topical application of glucocorticoids to areas affected by psoriasis can lead to the spread of the pathological process or relapse caused by the development of tolerance, as well as the risk of generalized pustular psoriasis and systemic toxicity caused by skin dysfunction.
Do not use the preparation for more than 2 weeks without a break. With prolonged use on large areas of the skin, the incidence of side effects and the possibility of developing edema, hypertension, hyperglycemia, and a decrease in body resistance increase.
With external use of the preparation, a decrease in the production of ACTH by the pituitary gland, suppression of the adrenal gland-pituitary gland, a decrease in the level of cortisol in the blood and the development of iatrogenic Cushing's syndrome, which disappears after discontinuation of the preparation, are possible.
If an infection develops at the site of application of the ointment / gel, appropriate antibacterial or antifungal treatment should be carried out. If the symptoms of the infection do not disappear, it is necessary to stop using the preparation for the period of treatment of the infection.
Avoid applying the preparation to the eyelids or skin around the eyes in patients with closed-angle and open-angle glaucoma, as well as in patients with cataracts due to a possible increase in the severity of symptoms of the disease. Avoid getting the preparation in the eyes. In case of skin irritation at the site of application of the ointment / gel, the preparation should be discontinued.
On the skin of the face, as well as in the inguinal region, apply only in case of special need, since there may be an increase in absorption and a high risk of side effects (telangiectasia, dermatitis perioralis), even after a short application.
The preparation should be used with caution in the presence of subcutaneous tissue atrophy, mainly in the elderly.
Since the ointment contains propylene glycol, the preparation may cause skin irritation when applied.
Since the ointment contains lanolin, its use may cause local reactions (eg contact dermatitis).
The gel contains parahydroxybenzoates, which may cause allergic reactions (possibly delayed).
The gel contains propylene glycol, which may cause skin irritation.
Use during pregnancy and lactation. The preparation is contraindicated during pregnancy. For the period of treatment, breastfeeding should be discontinued.
Pregnancy. As a result of animal studies, it has been confirmed that corticosteroids have a teratogenic effect even when used in low doses. Teratogenic effects in animals have also been confirmed when powerful corticosteroids are applied to the skin. Controlled studies to evaluate the possible teratogenic effect in pregnant women when applied topically to the skin have not been performed, therefore, data on the effects of the preparation on the course of pregnancy and / or embryonic development, fetal development, childbirth, postnatal development are insufficient. The potential risk to humans is unknown.
Flucinar should not be used during pregnancy unless absolutely necessary, if the potential benefit to the mother outweighs the risk to the fetus. The preparation is contraindicated in the first trimester of pregnancy.
breastfeeding period. It is not known whether fluocinolone acetonide can pass into breast milk after topical application. After oral administration of corticosteroids, significant concentrations in breast milk, which can cause side effects in a newborn child, have not been determined.
Children. The preparation is not used in children under the age of 2 years.
The ability to influence the reaction rate when driving vehicles or working with other mechanisms. The preparation does not limit mental and motor ability, as well as the ability to drive vehicles and work with mechanisms.
Interactions
The preparation can be used with antimicrobial agents of local and systemic action. combined use with systemic corticosteroids increases the effectiveness of the drug, but at the same time increases the likelihood of side effects. the combined use of the preparation with NSAIDs increases the risk of systemic and local side effects. may enhance the effect of antihypertensive, diuretic, antiarrhythmic preparations, potassium preparations. diuretic preparations (except for potassium-sparing ones) increase the likelihood of developing hypokalemia. during treatment with the preparation, it is not recommended to vaccinate against smallpox, as well as to carry out other types of immunization (especially with prolonged use on large areas of the skin) due to the possible lack of an adequate immunological response in the form of the production of appropriate antibodies.
The preparation can enhance the effect of immunosuppressive and weaken the effect of immunostimulating preparations.
Overdose
With prolonged use on large areas of the skin, overdose symptoms may occur, which are manifested by an increase in the severity of side effects, including burning of the skin at the site of application of the preparation, glucosuria, edema, hypertension, and a decrease in the body's resistance to infections. itching, hyperglycemia, Itsenko-Cushing's syndrome are possible. symptomatic treatment against the background of the gradual withdrawal of the preparation.
Storage conditions
At a temperature not higher than 25°C. do not freeze.
Tags: Flucinar
Products viewed
2 x MULTILAC BABY SYNBIOTIC DROPS 10ML - MADE IN POLAND - FREE SHIPPING
Product descriptionMultilac Baby drops are a dietary supplement to be used during and after antibiotic therapy in infants, children and adults. It can also be used when the intestinal microflora is weakened or in the autumn and winter period. Multilac Baby contains Lactobacillus rhamnosus GG bacteri..
$20.72
Buyers Online
- Customer from Port Charlotte registered for an account
- Customer from London registered for an account
- Customer from DUBLIN 7 registered for an account
- Customer from Kennesaw registered for an account
- Customer from Riga registered for an account
- Customer placed a new order for Galstena oral drops 50 ml — Made in Austria — Free Delivery
- Customer placed a new order for CEREBROLYSIN 10ML 5 VILAS - MADE IN AUSTRIA - FREE SHIPPING
- Customer placed a new order for Duxet 60mg 28 capsules — Made in Turkey — Free Delivery
- Customer placed a new order for 2 x MAXIGRA GO 25MG 4 TABS — MADE IN POLAND — FREE SHIPPING
- Customer placed a new order for 2 x FOTIL EYE DROPS 5ML — MADE IN FINLAND — FREE SHIPPING
- Customer from Maple Ridge updated their account details
- Customer from Maple Ridge logged in
- Customer from Gilmanton logged in
- Customer from Lake Stevens logged in
- Customer placed a new order for Lidocain spray 10% 38g — Made in Hungary — Free Delivery
- Customer placed a new order for Soleron 100mg 30 tablets — Made in Ukraine — Free Delivery
- Customer from Gilmanton logged in
- Customer from Founex logged in
- Customer from Miami Beach placed a new order for Essentiale N solution for injection 250mg/5ml, 5 ml x 5 ampoules — Made in Spain — Free Delivery
- Customer from Miami Beach registered for an account